Charles River Laboratories International Community
Create a narrative
WA
Based on Analyst Price Targets
Cost Efficiency And Digital Strategy Propel Earnings Amidst Pharma Industry Challenges
US$224.01
FV
11.5% undervalued intrinsic discount4.12%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
about 15 hours agoauthor updated this narrative